Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: StocksDATsoar who wrote (58028)	8/4/2000 1:02:01 PM
From: Jim Bishop	Read Replies (2) \| Respond to of 150070

DNAP news :-) SARASOTA, Fla.--(BUSINESS WIRE)--Aug. 4, 2000--DNAPrint genomics (Pink Sheets:DNAP) has entered into a license agreement with privately held Geospiza Inc., of Seattle, WA. Under the terms of the license, DNAPrint genomics will participate in the beta-testing of Geospiza's DNA sequence information management system for standard DNA sequencing files. During the term of the license, which is extendible, DNAPrint genomics will be one of a small group of organizations that will use and test this system. The system is called Finch(TM)-Server; it manages standard DNA sequencing data files within an internet-based relational database structure. The system will be used by DNAPrint genomics for its SNP location re-sequencing effort and to communicate standard DNA sequence data to partners and customers on a daily basis. SNP location discovery is accomplished by long read DNA sequencing and makes use of NCBI human genome data as a "roadmap". This process is the first step of the company's research and development. The license obviates the need for DNAPrint genomics to develop a standard DNA sequence relational database system necessary for its SNP location discovery project, which is peripheral to the company's main objective of developing genetic algorithms and pharmacogenomics and disease knowledge bases. About the Finch-Server The data management system developed by Geospiza is used to organize DNA sequencing workflow and automate quality analysis of DNA sequence files. For SNP discovery efforts, standardized quality control assessment is crucial, and accurate and efficient quality control assessment has been a bottleneck for many organizations. About DNAPrint genomics DNAPrint genomics, Inc. provides practitioners of genomic research and personalized medicine with a comprehensive system for complex trait dissection and patient classification. DNAPrint genomics Inc. was founded by a group of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. For more information about the company, please visit www.dnaprint.com. About Geospiza Geospiza, Inc., Seattle, WA, was founded in 1997 and designs software systems to facilitate high-throughput data management and analysis with state-of-the-art algorithms commonly used in bioinformatics. For more information, please visit www.geospiza.com. Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties. The Company's actual results could differ materially from those contained in such statements. Factors that could cause or contribute to such differences include unexpected shortages of critical components, rescheduling or cancellation of customer orders, the timing and market acceptance of new product introductions by the Company and its competitors, and general competition and price pressures in the marketplace. --30--pp/mi* CONTACT: For scientific inquiries: DNAPrint genomics, Inc., Sarasota Dr. Tony Frudakis, 941/351-4543 or All other inquiries: Richard Craig Hall, 941/341-0136 KEYWORD: FLORIDA WASHINGTON INDUSTRY KEYWORD: MEDICAL BIOTECHNOLOGY HARDWARE SOFTWARE MARKETING AGREEMENTS PRODUCT Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *